Four people in Denmark who developed serious eye conditions after using popular weight-loss and diabetes drugs Wegovy and ...

While headlines about 'Ozempic face' warn that the rapid weight loss associated with GLP-1 drugs can prematurely age people's ...

The authority said it has received 43 claims from patients who believe they developed the condition known as NAION after ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Four patients in Denmark, who experienced vision loss after using Novo Nordisk’s popular weight-loss and diabetes drugs ...

A Novo Nordisk challenge has driven Regen Doctors to voluntarily discontinue compounded semaglutide product claims, adding to ...

MILLIONS of us are on them, and the rest of us are fat jab-curious, intrigued by the ‘miracle’ shots melting waistlines ...

An estimated 12 percent of U.S. adults are currently taking a GLP-1 drug, such as Ozempic or Wegovy, a KFF survey last week ...

Four Danish patients who experienced vision loss after using Novo Nordisk's Wegovy and Ozempic were awarded compensation ...

HealthDay News — People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications. The company announced that ...

Novo Nordisk is quietly coming out of the storm despite the prevailing pessimism, especially among retail investors. Click ...

Low doses of these popular drugs can reverse ageing, scientists say - Researchers say findings provide evidence for ...